Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Derks

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|May 7, 2008
Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient miceHilde Herrema, Terry G J Derks, Theo H van Dijk, et al.
Orphanet Journal of Rare Diseases|June 4, 2021
A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type IaVaneisse C L Monteiro, Bibiana M de Oliveira, Bruna B Dos Santos, et al.
Proteomics. Clinical Applications|December 8, 2010
The feasibility of MS and advanced data processing for monitoring Schistosoma mansoni infectionCrina I A Balog, Theodore Alexandrov, Rico J Derks, et al.
Nature Genetics|January 19, 2023
Genome-wide RNA polymerase stalling shapes the transcriptome during agingAkos Gyenis, Jiang Chang, Joris J P G Demmers, et al.
Journal of Inherited Metabolic Disease|December 17, 2020
The potential of dietary treatment in patients with glycogen storage disease type IVTerry G J Derks, Fabian Peeks, Foekje de Boer, et al.
Journal of Inherited Metabolic Disease|January 8, 2024
Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessmentTerry G J Derks, Annieke Venema, Clara Köller, et al.
Journal of Inherited Metabolic Disease|March 14, 2014
Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiencyTerry G J Derks, Catharina M L Touw, Graziela S Ribas, et al.
Hepatology (Baltimore, Md.)|July 21, 2017
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type IaBrenda S Hijmans, Andreas Boss, Theo H van Dijk, et al.
Molecular Genetics and Metabolism|December 4, 2014
BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrationsDanique van Vliet, Karen Anjema, Rianne Jahja, et al.
Journal of Inherited Metabolic Disease|September 17, 2014
In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseasesTatiéle Nalin, Koen Venema, David A Weinstein, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|May 7, 2008
Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient miceHilde Herrema, Terry G J Derks, Theo H van Dijk, et al.
Orphanet Journal of Rare Diseases|June 4, 2021
A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type IaVaneisse C L Monteiro, Bibiana M de Oliveira, Bruna B Dos Santos, et al.
Proteomics. Clinical Applications|December 8, 2010
The feasibility of MS and advanced data processing for monitoring Schistosoma mansoni infectionCrina I A Balog, Theodore Alexandrov, Rico J Derks, et al.
Nature Genetics|January 19, 2023
Genome-wide RNA polymerase stalling shapes the transcriptome during agingAkos Gyenis, Jiang Chang, Joris J P G Demmers, et al.
Journal of Inherited Metabolic Disease|December 17, 2020
The potential of dietary treatment in patients with glycogen storage disease type IVTerry G J Derks, Fabian Peeks, Foekje de Boer, et al.
Journal of Inherited Metabolic Disease|January 8, 2024
Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessmentTerry G J Derks, Annieke Venema, Clara Köller, et al.
Journal of Inherited Metabolic Disease|March 14, 2014
Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiencyTerry G J Derks, Catharina M L Touw, Graziela S Ribas, et al.
Hepatology (Baltimore, Md.)|July 21, 2017
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type IaBrenda S Hijmans, Andreas Boss, Theo H van Dijk, et al.
Molecular Genetics and Metabolism|December 4, 2014
BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrationsDanique van Vliet, Karen Anjema, Rianne Jahja, et al.
Journal of Inherited Metabolic Disease|September 17, 2014
In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseasesTatiéle Nalin, Koen Venema, David A Weinstein, et al.
Pageof 17